["{\n\"step_by_step_thinking\": \"Given the patient has ER-positive breast cancer with one positive axillary lymph node, we know that hormone receptor analysis is used to understand the mechanisms of action of steroid and peptide hormones. Since the patient is on tamoxifen, a hormonal agent, it's likely that the primary focus of follow-up is on the effectiveness of this therapy. The documents suggest that advances in selection and treatment of patients with early-stage breast cancer are being made through prospective randomized trials. Considering these factors, we should prioritize monitoring the patient's response to tamoxifen and assess any changes in tumor markers or disease recurrence.\",\n\"answer_choice\": C"]